Who invested in Cadent Therapeutics?
Cadent Therapeutics's investors include Access Industries, Cowen Group, Atlas Venture/ Qiming, Clal Biotechnology Industries and Novartis Institutes for Biomedical Research.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2018, from 1 source
Reported by FinSMEs
Cadent Therapeutics's investors include Access Industries, Cowen Group, Atlas Venture/ Qiming, Clal Biotechnology Industries and Novartis Institutes for Biomedical Research.
Cadent Therapeutics has raised $40M across 1 round since 2018.
Cadent Therapeutics's most recent round was a Series B of $40M in Nov 2018.
Its most recent round, $40M in Nov 2018, is also its largest on record.
Cadent Therapeutics's first round on record, in Nov 2018, was backed by Access Industries, Cowen Group and Atlas Venture/ Qiming and 2 others.
Cadent Therapeutics's latest named round is a Series B, in Nov 2018.
Cadent Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.